StockNews.com Begins Coverage on Titan Pharmaceuticals (NASDAQ:TTNP)

StockNews.com started coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance Shares of NASDAQ:TTNP opened at $0.42 on Tuesday. The firm has a fifty day moving average price of […]

Leave a Reply

Your email address will not be published.

Previous post Summit Financial Group (NASDAQ:SMMF) Research Coverage Started at StockNews.com
Next post How Erick Fedde expanded his pitch arsenal in Korea to get back to the big leagues with the Chicago White Sox